-
The market may attempt to rebound amid consolidation, but it seems unsustainable given the overall negative sentiment.
-
Indian Energy Exchange also joined the bulls' party, rising over 4 percent to Rs 144, the highest closing level since December 19 last year and formed healthy bullish candle on the daily charts with strong volumes. The stock has been making higher highs higher lows for fifth straight session, with expansion of Bollinger band on both sides.
-
Thyrocare Technologies rose nearly 2 percent to Rs 635 and formed bullish candle on the daily charts with long upper shadow, which resembles bullish Harami kind of pattern formation, which is bullish reversal pattern. The trading volume was high on the same day.
-
Post the recent correction, Mahindra CIE Automotive has been consolidating in a broad range which indicates that the trend has changed from down to sideways. The volumes in last few days are low and hence a breakout with good volumes is required for a positive momentum.
-
Traders should continue to ride the trend with a trailing stop-loss method and also look to add positions on any corrective declines in Coromandel International.
-
The S&P BSE Midcap index shed 1.31 percent, Smallcap Index was down 0.90 percent and S&P BSE Largecap Index fell 0.59 percent last week.
-
Ashwani Gujral of ashwanigujral.com recommends buying Indraprastha Gas with a stop loss of Rs 320, target of Rs 345, Hindustan Unilever with a stop loss of Rs 1730, target of Rs 1765 and Titan Company with a stop loss of Rs 1110, target of Rs 1140.
-
Here are the top 10 stocks from brokerages which could give up to 60 percent returns
-
For the week, Reliance Industries gained 12.31 percent while IDBI Bank jumped 18.88 percent. TCS added 3.56 percent while HCL Technologies gained 4.17 percent and Shilpa Medicare registered a gain of 5.39 percent.
-
Prakash Gaba of prakashgaba.com recommends buying Hindustan Unilever with target at Rs1480 and stop loss at Rs 1452 and Tata Global Beverage with target at Rs 295 and stop loss at Rs 286.
-
"Till Nifty sustains above 9900 levels, bounce back from current level cannot be ruled out," says Rajesh Agarwal of AUM Capital.
-
The reaction to the US-China trade war on equity markets was nothing short of a bloodbath. Asian markets plunged while back home Sensex and Nifty recorded a cut of over 1 percent. The rout witnessed by the Indian market on Friday has eroded Rs 1.57 crore of investor wealth.
-
Here is the list of 10 stocks that can give up to 76 percent return.
-
Jubilant Foodworks, BASF and Shoppers Stop, among others, are being tracked by investors on Friday.
-
Stocks which gave multibaggers returns in the December quarter of 2016 include names like SE Power, Kushal Tradelink, India Metals, Vama Industries, HM Sugar Mills, Indokem, Atlas Jewellery, Niraj Cement etc. among others.
-
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Shilpa Medicare, IFCI and Hindustan Zinc and sell Zee Entertainment and HPCL.
-
On CNBC-TV18's special show 'Super17', market experts SP Tulsian, Prakash Diwan, Dipan Mehta and Daljeet Singh Kohli outlined a list of 17 stocks they are bullish on for the coming year 2017.
-
Ashwani Gujral of ashwanigujral.com advises buying MRPL, Shilpa Medicare, Bharat Electronics, Engineers India and Syngene International.
-
The market now looks under-owned says SP Tulsian of sptulsian.com in an interview to CNBC-TV18. There will be some profit booking but remain prepared to see a level of 8,500 on the Nifty for the December series, he adds.
-
SP Tulsian of sptulsian.com tells CNBC-TV18 why he is positive on only select information technology stocks and why his take on Trident as trouble brewing for its competitor Welspun might mean more business for the company.
-
According to Prakash Gaba of prakashgaba.com, Axis Bank may test Rs 565 while Shilpa Medicare may climb to Rs 650.
-
Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma Advance Research Company, Magma Fincorp, Balrampur Chini and JK Lakshmi Cement.
-
CA Rudramurthy BV at Vachana Investments is of the view that Shilpa Medicare is an attractive buy and feels that the stock may double in 2-3 years.
-
SP Tulsian of sptulsian.com is of the view that Shilpa Medicare may touch Rs 355-360 in the near term.
